placebo circadin

DRUG2 trials

Sponsors

Neurim Pharmaceuticals Ltd.

Conditions

Primary Insomnia

Phase 2

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

CompletedNCT00816673

Neurim Pharmaceuticals Ltd.Primary Insomnia

Start: 1996-09-30End: 1997-09-30Updated: 2024-11-14

Phase 3

Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients

CompletedNCT00397189

Neurim Pharmaceuticals Ltd.Primary Insomnia

Start: 2006-10-31End: 2009-04-30Updated: 2018-05-01

Related Papers

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.

2010-11-2469 citations